Senseonics Holdings (SENS) Shares Outstanding (2014 - 2026)
Senseonics Holdings' (SENS) quarterly Shares Outstanding (Entity) came in at $41.8 million in Q1 2026, up 27.77% year-on-year from $32.7 million in Q1 2025, and up 1.28% on a QoQ basis from $41.3 million in Q4 2025.
Senseonics Holdings (SENS) Shares Outstanding (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 12 years of Shares Outstanding (Entity) data on file, last reported at $41.8 million in Q1 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 27.77% year-over-year to $41.8 million in Q1 2026; TTM through Mar 2026 was $41.8 million, a 27.77% increase from a year earlier, with the FY2025 full-year figure at $41.3 million, up 38.63% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $41.8 million, up from $41.3 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for SENS reached as high as $41.8 million in Q1 2026 and fell as low as $23.2 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $29.6 million across 5 years, with a median of $26.5 million in 2024.
- Across the five-year window, Shares Outstanding (Entity) gained 3.3% in 2024 and jumped 52.18% in 2025, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $24.0 million in 2022, then rose by 10.58% to $26.5 million in 2023, then advanced by 12.25% to $29.8 million in 2024, then surged by 38.63% to $41.3 million in 2025, then increased by 1.28% to $41.8 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $41.8 million in Q1 2026, $41.3 million in Q4 2025, and $40.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | Senseonics Holdings | 203.54 Mn | 139.22 Mn | 6.94 Mn | 45.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.82 Mn |
| Dec 31, 2025 | 41.73 Mn |
| Sep 30, 2025 | 44.95 Mn |
| Jun 30, 2025 | 40.67 Mn |
| Mar 31, 2025 | 35.94 Mn |
| Dec 31, 2024 | 31.49 Mn |
| Sep 30, 2024 | 31.04 Mn |
| Jun 30, 2024 | 30.83 Mn |
| Mar 31, 2024 | 30.73 Mn |
| Dec 31, 2023 | 28.40 Mn |
| Sep 30, 2023 | 29.62 Mn |
| Jun 30, 2023 | 28.36 Mn |
| Mar 31, 2023 | 24.87 Mn |
| Dec 31, 2022 | 23.40 Mn |
| Sep 30, 2022 | 23.62 Mn |
| Jun 30, 2022 | 23.21 Mn |
| Mar 31, 2022 | 22.80 Mn |
| Dec 31, 2021 | 21.12 Mn |
| Sep 30, 2021 | 22.27 Mn |
| Jun 30, 2021 | 21.59 Mn |